+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bladder Cancer Drugs Market Research Reports

From
Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2020 - Product Thumbnail Image

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2020

  • Drug Pipelines
  • September 2020
  • 90 Pages
From
From
From
From
Bladder Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Bladder Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1855 Pages
From
From
From
Bladder Cancer: Epidemiology Forecast to 2028 - Product Thumbnail Image

Bladder Cancer: Epidemiology Forecast to 2028

  • Report
  • February 2020
  • 49 Pages
From
Muscle Invasive Bladder cancer- Pipeline Insight, 2020 - Product Thumbnail Image

Muscle Invasive Bladder cancer- Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Bladder cancer - Pipeline Insight, 2020 - Product Thumbnail Image

Bladder cancer - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Bladder Cancer Drugs Global Market Report 2020 - Product Thumbnail Image

Bladder Cancer Drugs Global Market Report 2020

  • Report
  • December 2019
  • 200 Pages
From
From
From
From
Bladder Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Bladder Cancer Treatment Drugs Markets in China

  • Report
  • May 2020
  • 235 Pages
From
Loading Indicator

Bladder cancer is the fourth most common cancer among males in the US and due to its prevalence among the over 65s, diagnoses are set to increase in ageing populations worldwide. Reports in the Bladder Cancer section cover a variety of areas, such as the latest R&D and clinical trials taking place in universities, hospitals and other research centres around the world. Explore epidemiology, unmet needs, drug development (cytotoxic, immunotherapy agents, etc.), supply & demand, business development strategies, licensing and partnership opportunities, and the activities of key industry players such as Bristol-Myers Squibb, Spectrum Pharmaceuticals, Bioniche Life Sciences, Endo Pharmaceuticals, Eli Lilly and Sanofi-Aventis. Show Less Read more

adroll